Effects of ocrelizumab on disability progression and inflammatory activity in multiple sclerosis patients during the two-year follow-up

Creative Commons License

Özakbaş S., Baba C., Kaya E., Özçelik S., Özdoğar A. T., Daştan S.

ECTRIMS 2022, Amsterdam, Netherlands, 26 - 28 October 2022, vol.28, no.1084, pp.862

  • Publication Type: Conference Paper / Summary Text
  • Volume: 28
  • City: Amsterdam
  • Country: Netherlands
  • Page Numbers: pp.862
  • Dokuz Eylül University Affiliated: Yes